27441638|t|Potentiation of LPS - Induced Apoptotic Cell Death in Human Hepatoma HepG2 Cells by Aspirin via ROS and Mitochondrial Dysfunction: Protection by N-Acetyl Cysteine
27441638|a|Cytotoxicity and inflammation - associated toxic responses have been observed to be induced by bacterial lipopolysaccharides (LPS) in vitro and in vivo respectively. Use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, has been reported to be beneficial in inflammation - associated diseases like cancer, diabetes and cardiovascular disorders. Their precise molecular mechanisms, however, are not clearly understood. Our previous studies on aspirin treated HepG2 cells strongly suggest cell cycle arrest and induction of apoptosis associated with mitochondrial dysfunction. In the present study, we have further demonstrated that HepG2 cells treated with LPS alone or in combination with aspirin induces subcellular toxic responses which are accompanied by increase in reactive oxygen species (ROS) production, oxidative stress, mitochondrial respiratory dysfunction and apoptosis. The LPS / Aspirin induced toxicity was attenuated by pre-treatment of cells with N-acetyl cysteine (NAC). Alterations in oxidative stress and glutathione - dependent redox-homeostasis were more pronounced in mitochondria compared to extra - mitochondrial cellular compartments. Pre-treatment of HepG2 cells with NAC exhibited a selective protection in redox homeostasis and mitochondrial dysfunction. Our results suggest that the altered redox metabolism, oxidative stress and mitochondrial function in HepG2 cells play a critical role in LPS / aspirin - induced cytotoxicity. These results may help in better understanding the pharmacological, toxicological and therapeutic properties of NSAIDs in cancer cells exposed to bacterial endotoxins.
27441638	0	12	Potentiation	T058	UMLS:C0279023
27441638	16	19	LPS	T103	UMLS:C0023810
27441638	22	29	Induced	T038	UMLS:C0007994
27441638	30	50	Apoptotic Cell Death	T038	UMLS:C0162638
27441638	54	80	Human Hepatoma HepG2 Cells	T017	UMLS:C2717940
27441638	84	91	Aspirin	T103	UMLS:C0004057
27441638	96	99	ROS	T103	UMLS:C0162772
27441638	104	129	Mitochondrial Dysfunction	T033	UMLS:C4021734
27441638	145	162	N-Acetyl Cysteine	T103	UMLS:C0001047
27441638	163	175	Cytotoxicity	T038	UMLS:C0596402
27441638	180	192	inflammation	T038	UMLS:C0021368
27441638	195	205	associated	T038	UMLS:C0243082
27441638	268	287	lipopolysaccharides	T103	UMLS:C0023810
27441638	289	292	LPS	T103	UMLS:C0023810
27441638	307	314	in vivo	T082	UMLS:C1515655
27441638	336	372	nonsteroidal anti-inflammatory drugs	T103	UMLS:C0003211
27441638	374	380	NSAIDs	T103	UMLS:C0003211
27441638	391	398	aspirin	T103	UMLS:C0004057
27441638	409	417	reported	T058	UMLS:C0700287
27441638	438	450	inflammation	T038	UMLS:C0021368
27441638	453	472	associated diseases	T038	UMLS:C0243083
27441638	478	484	cancer	T038	UMLS:C0006826
27441638	486	494	diabetes	T038	UMLS:C0011847
27441638	499	523	cardiovascular disorders	T038	UMLS:C0007222
27441638	611	618	studies	T062	UMLS:C0008972
27441638	622	629	aspirin	T103	UMLS:C0004057
27441638	630	637	treated	T058	UMLS:C0332293
27441638	638	649	HepG2 cells	T017	UMLS:C2717940
27441638	667	684	cell cycle arrest	T038	UMLS:C1155873
27441638	702	711	apoptosis	T038	UMLS:C0162638
27441638	728	753	mitochondrial dysfunction	T033	UMLS:C4021734
27441638	770	775	study	T062	UMLS:C0008972
27441638	811	822	HepG2 cells	T017	UMLS:C2717940
27441638	823	835	treated with	T058	UMLS:C0332293
27441638	836	839	LPS	T103	UMLS:C0023810
27441638	869	876	aspirin	T103	UMLS:C0004057
27441638	885	896	subcellular	T017	UMLS:C0729605
27441638	897	912	toxic responses	T038	UMLS:C3549372
27441638	950	973	reactive oxygen species	T103	UMLS:C0162772
27441638	975	978	ROS	T103	UMLS:C0162772
27441638	992	1008	oxidative stress	T038	UMLS:C0242606
27441638	1010	1047	mitochondrial respiratory dysfunction	T033	UMLS:C4021734
27441638	1052	1061	apoptosis	T038	UMLS:C0162638
27441638	1067	1070	LPS	T103	UMLS:C0023810
27441638	1073	1080	Aspirin	T103	UMLS:C0004057
27441638	1089	1097	toxicity	T037	UMLS:C0600688
27441638	1133	1138	cells	T017	UMLS:C0007634
27441638	1144	1161	N-acetyl cysteine	T103	UMLS:C0001047
27441638	1163	1166	NAC	T103	UMLS:C0001047
27441638	1184	1200	oxidative stress	T038	UMLS:C0242606
27441638	1205	1216	glutathione	T103	UMLS:C0017817
27441638	1229	1246	redox-homeostasis	T038	UMLS:C1156287
27441638	1271	1283	mitochondria	T017	UMLS:C0026237
27441638	1304	1317	mitochondrial	T017	UMLS:C0026237
27441638	1318	1339	cellular compartments	T017	UMLS:C1166607
27441638	1358	1369	HepG2 cells	T017	UMLS:C2717940
27441638	1375	1378	NAC	T103	UMLS:C0001047
27441638	1415	1432	redox homeostasis	T038	UMLS:C1156287
27441638	1437	1462	mitochondrial dysfunction	T033	UMLS:C4021734
27441638	1501	1517	redox metabolism	T038	UMLS:C1156287
27441638	1519	1535	oxidative stress	T038	UMLS:C0242606
27441638	1540	1553	mitochondrial	T017	UMLS:C0026237
27441638	1566	1577	HepG2 cells	T017	UMLS:C2717940
27441638	1602	1605	LPS	T103	UMLS:C0023810
27441638	1608	1615	aspirin	T103	UMLS:C0004057
27441638	1626	1638	cytotoxicity	T038	UMLS:C0596402
27441638	1752	1758	NSAIDs	T103	UMLS:C0003211
27441638	1762	1774	cancer cells	T017	UMLS:C0334227
27441638	1786	1806	bacterial endotoxins	T103	UMLS:C0014264